[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554285":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":26,"responsibleParty":45,"collaborators":18,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":18,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":18,"enrollmentInfo":58,"targetDuration":18,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":18,"overallStatus":29,"whyStopped":18,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Oslo University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Temperament Based Therapy with Support (TBT-S)","EXPERIMENTAL","TBT-S in addition to treatment as usual",[13],"Behavioral: Temperament Based Therapy with Support (TBT-S)",{"label":15,"type":16,"description":17,"interventionNames":18},"Treatment as Usual (TAU)","NO_INTERVENTION","Treatment as Usual",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"BEHAVIORAL","Participants included in the intervention arm will receive TBT-S (5-day treatment) in addition to treatment as usual (TAU)",[9],[25],"TBT-S",[27],{"facility":28,"status":29,"city":30,"state":18,"zip":18,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Oslo University Hospital, Regional Department for Eating Disorders","RECRUITING","Oslo","Norway","NO",{"type":34,"coordinates":35},"Point",[36,37],10.74609,59.91273,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":18,"email":44},"Kristin Stedal, PhD","CONTACT","+4791321971","krsted@ous-hf.no",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Kristin Stedal","Senior Researcher","100554285","effectiveness-trial-of-temperament-based-therapy-with-support-tbt-s-100554285",false,"NCT06497101","Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)","Effectiveness of Temperament Based Therapy With Support (TBT-S): A Novel 5-day Treatment for Anorexia Nervosa","Inclusion Criteria:\n\n* Age ≥18, all genders\n* A Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosed anorexia nervosa disorder (F50.0, F50.01, F50.02, also including F50.9 - atypical anorexia nervosa)\n* Willingness to have Support(s) participate in treatment\n* Medically stable\n\nExclusion Criteria:\n\n* Intellectual developmental disorder or intellectual disability; psychotic disorder or other psychopathology that may affect or prevent participation in the study\n* diagnosed alcohol or other substance use disorder within 3 months prior to study initiation\n* ongoing inpatient treatment at the time of study enrollment (participants currently in inpatient care must be discharged and engaged in outpatient treatment before participating in the TBT-S week","ALL","18 Years",{"count":59,"type":60},120,"ESTIMATED","INTERVENTIONAL",[63],"NA","The main aim of this project is to determine the short and long-term effectiveness of an out-patient treatment for patients with anorexia nervosa. Specifically, we will measure whether TBT-S in addition to treatment as usual (TAU) will be more effective than TAU alone in reducing eating disorder psychopathology. Assessments will be conducted at four timepoints; pre and post TBT-S, and at 3 and 12 months follow-up. Primary outcome measure is eating disorder psychopathology, with the hypothesis that patients receiving TBT-S in addition to TAU will show significantly greater reduction in eating disorder psychopathology from TBT-S treatment admission to 3 month follow-up, compared to controls.",[66],"Anorexia Nervosa","2026-02-26",{"date":69,"type":70},"2026-03-02","ACTUAL",{"date":72,"type":70},"2024-11-15",{"date":74,"type":60},"2028-09-01",{"name":5,"class":6},1]